{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:15:55Z","timestamp":1791137755363,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH069696"],"award-info":[{"award-number":["MH069696"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS44169"],"award-info":[{"award-number":["NS44169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.nbd.2008.05.005","type":"journal-article","created":{"date-parts":[[2008,5,24]],"date-time":"2008-05-24T06:07:50Z","timestamp":1211609270000},"page":"298-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Paula A.","family":"Desplats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.05.005_bib1","first-page":"1154","article-title":"The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells","volume":"8","author":"Archer","year":"1994","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.nbd.2008.05.005_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2004.12.036","article-title":"Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo","volume":"45","author":"Arlotta","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.05.005_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","article-title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum","volume":"28","author":"Arlotta","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.005_bib4","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1074\/jbc.275.14.10315","article-title":"Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors","volume":"275","author":"Avram","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.05.005_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj20020496","article-title":"COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein","volume":"368","author":"Avram","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2008.05.005_bib6","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/nar\/gkg511","article-title":"SiteSeer: visualisation and analysis of transcription factor binding sites in nucleotide sequences","volume":"31","author":"Boardman","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2008.05.005_bib7","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2008.05.005_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.05.005_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.05.005_bib10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1182\/blood-2006-05-021790","article-title":"BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes","volume":"108","author":"Cismasiu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2008.05.005_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.005_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","article-title":"Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease","volume":"96","author":"Desplats","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.05.005_bib13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.05.005_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/mcne.1996.0041","article-title":"Excitotoxic brain lesion modifies binding to a USF binding site acting as a negative regulatory element in the Protease nexin-1 promoter","volume":"8","author":"Erno","year":"1996","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.005_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","article-title":"The basal ganglia: learning new tricks and loving it","volume":"15","author":"Graybiel","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2008.05.005_bib15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.005_bib16","doi-asserted-by":"crossref","first-page":"41299","DOI":"10.1074\/jbc.M008408200","article-title":"Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain","volume":"275","author":"Hackam","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.05.005_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.05.005_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.05.005_bib20","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.modgep.2004.03.009","article-title":"CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis","volume":"4","author":"Leid","year":"2004","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.nbd.2008.05.005_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2008.05.005_bib23","doi-asserted-by":"crossref","first-page":"36796","DOI":"10.1074\/jbc.274.51.36796","article-title":"Identification of COUP-TF as a transcriptional repressor of the c-mos proto-oncogene","volume":"274","author":"Lin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.05.005_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/ISB-00143","article-title":"Genome-wide prediction and analysis of function-specific transcription factor binding sites","volume":"4","author":"Long","year":"2004","journal-title":"In Silico Biol."},{"key":"10.1016\/j.nbd.2008.05.005_bib25","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.005_bib27","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1176\/jnp.17.1.119","article-title":"Huntington's disease patients show impaired perception of disgust in the gustatory and olfactory modalities","volume":"17","author":"Mitchell","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.005_bib29","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.05.005_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00018-003-3013-z","article-title":"Polyglutamine diseases: a transcription disorder?","volume":"60","author":"Okazawa","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2008.05.005_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.nbd.2008.05.005_bib33","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.05.005_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cell.2004.06.022","article-title":"Huntington's disease: new paths to pathogenesis","volume":"118","author":"Ross","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.005_bib35","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib36","series-title":"TESS: Transcription Element Search Software on the WWW. Technical Report CBIL","author":"Schug","year":"1997"},{"key":"10.1016\/j.nbd.2008.05.005_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3940(02)00210-0","article-title":"Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome","volume":"324","author":"Shim","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.05.005_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib39","doi-asserted-by":"crossref","first-page":"14403","DOI":"10.1073\/pnas.2436349100","article-title":"BDNF induces translocation of initiation factor 4E to mRNA granules: evidence for a role of synaptic microfilaments and integrins","volume":"100","author":"Smart","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.05.005_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","article-title":"Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection","volume":"56","author":"Spargo","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2008.05.005_bib41","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.05.005_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jnr.21046","article-title":"Striatal specificity of gene expression dysregulation in Huntington's disease","volume":"84","author":"Thomas","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.05.005_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1471-4159.2001.00027.x","article-title":"Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy","volume":"76","author":"Thomas","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.05.005_bib45","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00450-3","article-title":"Insoluble TATA-binding protein accumulation in Huntington's disease cortex","volume":"109","author":"van Roon-Mom","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2008.05.005_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0006-291X(02)03069-3","article-title":"Homozygous deletions and point mutations of the Rit1\/Bcl11b gene in gamma-ray induced mouse thymic lymphomas","volume":"301","author":"Wakabayashi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2008.05.005_bib48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1037\/0894-4105.19.4.428","article-title":"Olfactory and auditory event-related potentials in Huntington's disease","volume":"19","author":"Wetter","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nbd.2008.05.005_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.05.005_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nbd.2008.05.005_bib51","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.05.005_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1101\/gr.8.3.319","article-title":"Identification of human gene core promoters in silico","volume":"8","author":"Zhang","year":"1998","journal-title":"Genome Res."},{"key":"10.1016\/j.nbd.2008.05.005_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:34:48Z","timestamp":1772141688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0969996108000934"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.05.005","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}